Teri Loxam
2020
In 2020, Teri Loxam earned a total compensation of $772.8K as Chief Financial Officer at SQZ Biotechnologies Co, a 57% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $156,800 |
|---|---|
| Option Awards | $139,775 |
| Salary | $400,000 |
| Other | $76,228 |
| Total | $772,803 |
Loxam received $400K in salary, accounting for 52% of the total pay in 2020.
Loxam also received $156.8K in non-equity incentive plan, $139.8K in option awards and $76.2K in other compensation.
Rankings
In 2020, Teri Loxam's compensation ranked 9,626th out of 13,090 executives tracked by ExecPay. In other words, Loxam earned more than 26.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,626 out of 13,090 | 27th |
Division Manufacturing | 4,134 out of 5,621 | 27th |
Major group Chemicals And Allied Products | 1,690 out of 2,254 | 25th |
Industry group Drugs | 1,482 out of 1,954 | 24th |
Industry Biological Products, Except Diagnostic Substances | 340 out of 411 | 17th |
Source: SEC filing on April 26, 2021.
Loxam's colleagues
We found four more compensation records of executives who worked with Teri Loxam at SQZ Biotechnologies Co in 2020.